Alan Majchrowicz Photography

  • Home
  • Blog
  • Archive
    • All Galleries
    • Search
    • Cart
    • Lightbox
    • Client Area
  • Facebook
  • Twitter
x

Search Results

Refine Search
Match all words
Match any word
Prints
Personal Use
Royalty-Free
Rights-Managed
(leave unchecked to
search all images)
71 images found
twitterlinkedinfacebook

Loading ()...

  • solduc_falls_53867.jpg
  • skagit_valley_50889b.jpg
  • skagit_valley_50882.jpg
  • samish_bay_64696.jpg
  • panther_falls_51379_50889b.jpg
  • palouse_51742.jpg
  • palouse_51637.jpg
  • olympic_national_park_65454.jpg
  • north_cascades_65770.jpg
  • north_cascades_65742.jpg
  • north_cascades_64564.jpg
  • north_cascades_61502.jpg
  • north_cascades_54538.jpg
  • north_cascades_61493.jpg
  • north_cascades_58194.jpg
  • north_cascades_54390.jpg
  • mckenzie_river_65519.jpg
  • butte_creek_falls_65488.jpg
  • butte_creek_falls_65496.jpg
  • Dead trees entombed in travertine deposits colored by thermophilic bacteria. Upper Terraces of Mammoth Hot Springs, Yellowstone National Park
    yellowstone_68025.jpg
  • Dead trees entombed in travertine deposits colored by thermophilic bacteria. Upper Terraces of Mammoth Hot Springs, Yellowstone National Park
    yellowstone_68021.jpg
  • Colorful travertine formations at Great Fountain Geyser Yellowstone National Park
    yellowstone_67744.jpg
  • Squaretop Mountain reflected in Green River, Bridger Wilderness, Wind River Range Wyoming
    wind_river_range_67170.jpg
  • Squaretop Mountain reflected in Green River, Bridger Wilderness, Wind River Range Wyoming
    wind_river_range_67138.jpg
  • Mount Helen and field of purple Asters growing in Upper Titcomb Basin, Bridger Wilderness, Wind River Range Wyoming
    wind_river_range_66700or.jpg
  • Island Lake and Fremont Peak, Bridger Wilderness, Wind River Range Wyoming
    wind_river_range_66373.jpg
  • Mount Bonneville and Little Bonneville Lake. Bridger Wilderness, Wind River Range Wyoming
    wind_river_range_66283b.jpg
  • Clouds glowing red and orange in the light of the setting sun reflected in still waters of the Snake River at Oxbow Bend, Grand Teton National Park Wyoming
    greand_teton_67566.jpg
  • Teton Range at Cunningham Ranch, Grand Teton National Park Wyoming
    grand_teton_67607.jpg
  • The Teton Range in morning light from Mormon Row, Grand Teton National Park Wyoming
    grand_teton_67411.jpg
  • T.A. Moulton Barn on Mormon Row, Grand Teton National Park Wyoming
    grand_teton_67410.jpg
  • grand_teton_67386bw.jpg
  • John Moulton Barn on Mormon Row, Grand Teton National Park Wyoming
    grand_teton_67219.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24730.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24729.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24727.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24726.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24725.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24724.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24723.jpg
  • Discarded syringes of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24719.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24715.jpg
  • Three packaged syringes of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24714.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24711.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24710.jpg
  • am_090821_24708.jpg
  • am_090821_24707.jpg
  • am_090821_24705.jpg
  • Travertine deposits colored by thermophilic bacteria, Mammtoth Hot Springs, Yellowstone National Park
    yellowstone_68060.jpg
  • Evening light over Titcomb Basin, Bridger Wilderness, Wind River Range Wyoming
    wind_river_range_66580or.jpg
  • Evening light over Titcomb Basin, Bridger Wilderness, Wind River Range Wyoming
    wind_river_range_66567.jpg
  • Teton Range at Cunningham Ranch, Grand Teton National Park Wyoming
    greand_teton_67605.jpg
  • grand_teton_4399.jpg
  • Cup of morning tea and daily medications.
    am_090821_24737.jpg
  • Cup of morning tea and daily medications.
    am_090821_24736.jpg
  • Cup of morning tea and daily medications.
    am_090821_24735.jpg
  • Cup of morning tea and daily medications.
    am_090821_24734.jpg
  • Cup of morning tea and daily medications.
    am_090821_24733.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24732.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24731.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24728.jpg
  • Close-up of Rebif syringe. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24722.jpg
  • Close-up of Rebif syringe. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24721.jpg
  • Close-up of Rebif syringe. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24720.jpg
  • Discarded syringes of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24718.jpg
  • Discarded syringes of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24717.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24716.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24713.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24712.jpg
  • am_090821_24709.jpg
  • am_090821_24706.jpg